Conclusion it is effective and safety in treating progressive stroke with Kingtag.
结论金特佳治疗进展性脑梗死安全有效。
We studied how heparin treatment for progressive stroke has been discarded in Sweden.
在本试验中，我们对瑞典进展性卒中患者肝素治疗的弃用情况进行了研究。
Objective To evaluate the therapeutic efficiency and safety in treating progressive stroke with Kingtag.
目的研究金特佳治疗进展性脑梗死的疗效和安全性。
Results - Use of heparin for progressive stroke declined from 7.5% (2001) to 1.6% (2008) of all patients with ischemic stroke.
结果：在所有缺血性卒中的患者中，使用肝素治疗进展性卒中的患者比例从2001年的7.5%下降到了2008年的1.6%。
Objective To observe the therapeutic efficacy of combination of low-molecular weight heparin and Batroxobin(DF-521)on progressive stroke.
目的观察低分子肝素钙联合东菱克栓酶治疗进展性脑梗死的疗效。
Conclusion: Intravenous drip of heparin sodium is recommended for those status progress rapidly after progressive stroke attack from 6 to 48 hours.
结论：进展性脑卒中发病后6 ~48小时，进展较快推荐静脉滴注普通肝素。
Objectives: To explore the risk factors of progressive ischemic stroke and to provide bases for its prevention.
目的：探讨进展性缺血性卒中的危险因素，为其预防提供依据。
For the foam-filled double tube structure, the stroke efficiency and the energy absorption efficiency under the outer tube tear failure mode is higher than that under the progressive buckling mode.
双管夹芯结构中外管撕裂模式的结构行程利用率和能量吸收效率高于相应的外管周期折叠模式。
Objective To investigate the effect of Sodium Ozagrel treating progressive thrombolic stroke.
目的了解丹奥治疗进展性血栓性卒中的疗效。
Conclusion Serum hs? CRP and SF level could be regarded as predictor for progressive ischemic stroke.
和血清铁蛋白(SF)水平，旨在探讨其在进展性缺血性脑卒中预测中的临床应用价值。
Conclusion Serum hs? CRP and SF level could be regarded as predictor for progressive ischemic stroke.
和血清铁蛋白(SF)水平，旨在探讨其在进展性缺血性脑卒中预测中的临床应用价值。
应用推荐